Safety and Exploratory Efficacy Study of SF0166 in the Treatment of Neovascular Age-Related Macular Degeneration (AMD)
Clinical trial NCT02914639 · COMPLETED
Trial details
- NCT number
- NCT02914639
- Sponsor
- OcuTerra Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-10-05
- Primary completion
- 2017-06-26
- Enrollment
- 44
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.